Voyager Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Voyager Therapeutics, Inc. (VYGR) had Lessee, Operating Lease, Liability, to be Paid, Year One of $7.76 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $7.76M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $7.76M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $9.98M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $9.98M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $7.76M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $7.76M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $9.98M 10-K · filed 2026-03-09 |
| 2025-09-30 | $9.98M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $9.98M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $9.98M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $9.91M 10-K · filed 2025-03-11 |
| 2021-12-31 | $8.85M 10-K · filed 2022-03-08 |
| 2021-09-30 | $8.70M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $8.47M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $8.47M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $7.82M 10-K · filed 2021-02-25 |
| 2020-09-30 | $6.14M 10-Q · filed 2020-11-09 |
| 2019-12-31 | $5.96M 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |